title: Idiotypic responses induced by tumor: an autocrine network.
authors.affiliation: IDEC Pharmaceuticals Corporation, La Jolla, CA 92037.
authors.forename: H
authors.initials: H
authors.lastname: Köhler
authors.forename: S
authors.initials: S
authors.lastname: Raychaudhuri
authors.forename: J J
authors.initials: JJ
authors.lastname: Chen
authors.forename: Y
authors.initials: Y
authors.lastname: Saeki
mesh_terms: D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000912:Antibodies, Neoplasm / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology; D007111:Immunity, Cellular; D007130:Immunoglobulin Idiotypes / Q000276:immunology*; D016233:Immunotherapy, Active; D009374:Neoplasms, Experimental / Q000276:immunology* / Q000628:therapy; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D007130:Immunoglobulin Idiotypes